SAN DIEGO, April 30, 2015 /PRNewswire/ -- ResMed (NYSE:
RMD) today announced its Lumis™ series of noninvasive ventilation
devices that combine personalized, simplified therapy with powerful
wireless connected care capabilities. The Lumis series builds upon
ResMed's legacy of innovation as a new option for patients with
respiratory challenges who are not dependent on continuous
ventilation.
"With its ease of use, customization capabilities and wireless
connectivity, the Lumis series offers important benefits for
patients, clinicians, and home medical equipment providers alike,"
said Luke Maguire, President of
ResMed's Cardio-Respiratory Care Global Business Unit. "Lumis joins
ResMed's Stellar and Astral lines as a new entry-level option for
care providers to efficiently and effectively manage the
respiratory stability of their patients."
The Lumis series comprises the Lumis 100 VPAP S, Lumis 100 VPAP
ST and Lumis 150 VPAP ST noninvasive ventilators that support a
variety of therapy modes, built-in wireless connectivity,
integrated humidification and intuitive simplicity that are the
hallmarks of the series.
Individually Responsive and Tailored for Comfort
Lumis ventilators are designed with a broad range of automatic
settings making it an ideal choice for a wide variety of
respiratory conditions and individual patient preferences. Lumis is
the first ResMed ventilation platform with IntelligentAir, a
collection of ResMed technologies that can tailor therapy to
individual breathing needs, making truly personalized ventilation
possible. The complete IntelligentAir suite for Lumis includes
iVAPS (ResMed's unique volume-assurance therapy mode), iBR (an
intelligent Backup Rate), and AutoEPAP (which maintains upper
airway patency), as well as other features to personalize and
fine-tune individual patient's synchrony and comfort (Vsync,
TiControl, and trigger and cycle settings).
ResMed engineers also kept comfort top of mind when designing
Lumis: each device features built-in HumidAir heated humidification
capabilities and the popular Climate Control Auto setting, which
automatically determines optimal humidification by adjusting to
ambient room conditions. Lumis is compatible with ClimateLineAir™
Oxy tubing that allows for added oxygen to be heated and
humidified, which is useful for patients with chronic obstructive
pulmonary disease. In addition, the Lumis optional Ramp and Ramp
Down features can ease the transition onto ventilation and back to
spontaneous breathing when therapy is complete.
Connected Care with AirView™
The Lumis series was designed with connected care capabilities
that can improve overall patient care and streamline patient
monitoring and therapy management. Lumis' built-in wireless
connectivity means that clinicians and home medical equipment
providers have next-day access to a wide range of their patients'
therapy parameters, including blood oxygen saturation when an
oximeter is attached. These data, along with therapy statistics and
trend data useful for home titration and monitoring, are
automatically and securely transmitted to AirView™, ResMed's
cloud-based patient management system. AirView also includes a
popular Remote Assist feature that providers can use to
troubleshoot common therapy questions and change therapy settings
remotely.
Built-in Simplicity and Ease-of-Use
Lumis devices are designed for simplicity and ease-of-use right
out of the box. Every device comes built for quick setup thanks to
an easy-to-read color screen, improved menu format, and simple
push-dial navigation. Lumis' QuickNav feature also allows for easy
toggling between the settings and monitoring screens to make it
easy to see the real-time impact of configuration changes.
Lumis is compatible with all ResMed Air Solutions accessories,
including the popular AirFit mask series, to allow for personalized
therapy as well as streamlined home medical equipment inventory
management.
The Lumis series is launching in select European markets today,
and a global rollout is planned in additional regions throughout
2015 and early 2016.
About ResMed
The global team at ResMed (NYSE:RMD) is
united in their commitment to changing lives with every
breath. With more than 4,000 employees and a presence in over
100 countries, the company has been pioneering new and innovative
devices and treatments for sleep-disordered breathing, chronic
obstructive pulmonary disease, and other key chronic diseases for
more than 25 years. ResMed's world-leading products and innovative
solutions improve the quality of life for millions of patients
worldwide, reduce the impact of chronic disease, and save
healthcare costs. For more information about ResMed and its
businesses, visit www.resmed.com or follow @resmed on Twitter.
ResMed
Contacts:
|
|
|
|
For News
Media
|
For
Investors
|
Alison
Graves
|
Agnes Lee
|
Global Corporate
Communications
|
Senior Director,
Investor Relations
|
O:
858-836-6789
|
O:
858-836-5971
|
news@resmed.com
|
investorrelations@resmed.com
|
Logo -
http://photos.prnewswire.com/prnh/20140310/LA79234LOGO-a
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/resmed-introduces-lumis-series-of-noninvasive-ventilators-for-personalized-simplified-and-connected-care-300074772.html
SOURCE ResMed Inc.